98%
921
2 minutes
20
This study investigated the chain length-dependent extraction efficiency of two cationic surfactants-dodecyltrimethylammonium bromide (C12, 12-carbon chain) and cetyltrimethylammonium bromide (C16, 16-carbon chain)-for reverse micelle extraction of prolamins from Baijiu Jiuzao (Chinese Baijiu distillers' grains). Although pH variations (4.0-9.0) had negligible effects, ethanol, ionic strength, and chaotropic agent demonstrated distinct chain length-dependent behaviors: ethanol increased C12's forward extraction efficiency by 10.6% (absolute) while enhancing C16's backward efficiency by 8.7%. Potassium chloride enhanced C16's forward efficiency by 4.7%, while potassium bromide significantly improved C12's backward efficiency by 15.9%. Guanidine hydrochloride consistently promoted C16 in both extraction phases. Dynamic light scattering demonstrated significant differences (p < 0.05) in reverse micelle sizes: C12 formed smaller empty reverse micelles (1.5 ± 0.2 nm) compared to C16 (2.5 ± 0.5 nm). During forward extraction, reverse micelles expanded significantly to 217.9 ± 6.3 nm (C12) and 311.2 ± 43.2 nm (C16). Backward extraction released prolamin particles of 449.0 ± 16.2 nm (C12) and 650.4 ± 29.7 nm (C16), confirming the size-exclusion-driven release mechanism. The more compact C12 reverse micelles correlated with lower total prolamin yield (26.6 ± 0.1% vs. 32.2 ± 0.1% for C16, p < 0.01) and substantially diminished bovine serum albumin recovery (5.2 ± 0.2% vs. 45.3 ± 2.5%, p < 0.01). Sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis corroborated these findings, further demonstrating that reverse micelle-extracted prolamins formed thermally stable dimers resistant to reductive cleavage. Combined with dynamic light scattering data (particle size range: 400-700 nm in the backward-extraction aqueous phase), these findings demonstrate that prolamin aggregates after reverse micelle extraction. These findings demonstrate that surfactant chain length as a key parameter for optimizing reverse micellar systems, where shorter-chain surfactants facilitate selective extraction, whereas longer chains enhance yields.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/jssc.70242 | DOI Listing |
Research (Wash D C)
September 2025
Institute of Medical Research, Northwestern Polytechnical University, Xi'an, China.
The inhibition of dependent glutamine metabolism is an effective treatment for triple-negative breast cancer (TNBC) starvation, but it is limited by compensatory glycolysis and inadequate delivery efficiency. Herein, we construct a pH-responsive size/charge-reprogrammed micelle with hierarchical delivery characteristics for TNBC suppression with glutamine depletion and vessel blockade. It consists of a positively charged prodrug micelle chemically grafted with the glutamine transport inhibitor V9302 as the inner core layer, the neovascular disruptor CA4P adsorbed in the middle layer, and a pH-responsive peelable polymer as the outer shell.
View Article and Find Full Text PDFLangmuir
September 2025
Polymer Research Institute, State Key Laboratory of Advanced Polymer Materials, Sichuan University, Chengdu 610065, China.
Switchable surfactants exhibit broad application potential due to their reversible response to external stimuli. The reversible mechanism of the CO-switchable surfactant ('-dodecyl-, -dimethyl-acetamidines, DDA) solubilization polycyclic aromatic hydrocarbons (PAHs) and the microscopic dynamic behavior of emulsification/demulsification were systematically studied using coarse-grained molecular dynamics simulations. The dynamic transition processes of protonation (DDA to DDA) and deprotonation (DDA to DDA) were successfully simulated.
View Article and Find Full Text PDFSmall
September 2025
South China Advanced Institute for Soft Matter Science and Technology, School of Emergent Soft Matter, Guangdong Provincial Key Laboratory of Functional and Intelligent Hybrid Materials and Devices, Guangdong Basic Research Center of Excellence for Energy and Information Polymer Materials, South Chi
Self-assembled poly(2-dimethylaminoethyl methacrylate)-poly(2-(diisopropylamino)ethyl methacrylate) (PDMA-PDPA) diblock copolymer nanoparticles are widely employed in biological applications, driving the need for a robust and scalable production method. Although polymerization-induced self-assembly (PISA) enables efficient nanoparticle synthesis at high solids content, its research and application to PDMA-PDPA are limited, likely due to kinetic trapping. Leveraging our recently developed generic time-resolved small-angle X-ray scattering (TR-SAXS) approach for PISA in non-polar media, a reversible addition-fragmentation chain transfer-mediated PDMA-PDPA PISA process in polar solvent that produces spherical micelles is examined.
View Article and Find Full Text PDFPhys Chem Chem Phys
September 2025
Department of Chemistry, Veer Narmad South Gujarat University (VNSGU), Udhna - Magdalla Road, Surat-395007, Gujarat, India.
This work reports the nanoscale micellar formation in single and mixed surfactant systems by combining an amphiphilic graft copolymer, Soluplus® (primary surfactant), blended with other polyoxyethylene (POE)-based nonionic surfactants such as Kolliphor® HS15, Kolliphor® EL, Tween-80, TPGS®, and Pluronics® P123 in an aqueous solution environment. The solution behaviour of these surfactants as a single system were analyzed in a wide range of surfactant concentrations and temperatures. Rheological measurements revealed distinct solution behaviour in the case of Soluplus®, ranging from low-viscosity () and fluid-like behavior at ≤20% w/v to a highly viscous state at ≥90% w/v, where the loss modulus ('') exceeded the storage modulus (').
View Article and Find Full Text PDFNanomedicine (Lond)
September 2025
Département des Technologies pour l'Innovation en Santé, Université Grenoble-Alpes, CEA-LETI, Grenoble, France.
Lung cancer remains the leading cause of cancer-related deaths worldwide, with limited curative options, particularly in advanced stages. Lipid-based nanocarriers, including liposomes, solid lipid nanoparticles (SLNs), nanostructured lipid carriers (NLCs), and lipid nanocapsules (LNCs), have emerged as promising drug delivery platforms owing to their biocompatibility, versatility, and potential for pulmonary administration. This review highlights recent advances in lipid nanocarriers for lung cancer therapy, with a particular focus on NLCs and LNCs.
View Article and Find Full Text PDF